Trial Profile
A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) [Agatolimod] In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 26 Jan 2011
Price :
$35
*
At a glance
- Drugs Agatolimod (Primary)
- Indications Mycosis fungoides
- Focus Adverse reactions; Therapeutic Use
- 26 Aug 2005 New trial record.